UNSPSC 51162303: Acetaminophen/aspirin/phenylpropanolamine

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class RE599. This VA Drug Class (RE599) classifies this compound as belonging to the group COLD REMEDIES, OTHER.

The first component of this combination drug is an analgesic and antipyretic with the molecular formula C8H9NO2, a preparation that US FDA recognizes as an active ingredient or moiety under Unique Ingredient Identifier 362O9ITL9D, chemically known as n-(4-hydroxyphenyl)acetamide but more generally known as acetaminophen, which bears U.S. National Institutes of Health Compound Identifier 1983. Acetaminophen comes in many forms, including base, acetate, cysteine, cysteinylglycine, di-methyl derivative, glucuronide, glutathione, hemisuccinate, mercapturate, and sulfate.

UNSPSC 51162303 Acetaminophen/aspirin/phenylpropanolamine is a Commodity code that in recent state and local procurement activity frames not as a specific drug formulation but as part of broader pharmaceutical and over-the-counter (OTC) product procurement. State and local governments are buying generic multi-source pharmaceuticals and OTC products through cooperative purchasing vehicles and direct county procurements to support community health, emergency response, and public health initiatives. The issuing bodies include individual county health departments (Seminole County, Florida) and multistate cooperative purchasing alliances administering on behalf of state agencies and participating municipalities and counties. Work solicited under the code spans vendor qualification as manufacturers or distributors of generic pharmaceuticals with specific National Drug Codes, pricing negotiations for fixed or net-price formats, compliance with current Good Manufacturing Practices and Drug Supply Chain Security Act requirements, and logistics coordination through authorized pharmaceutical wholesalers.

Recent activity shows geographic spread across Florida and the upper Midwest. Seminole County, Florida issued an IFB in June 2026 seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries and a due date of July 26, 2023 (note: the posting date of June 30, 2026 and due date of July 26, 2023 represent a data inconsistency in the source). The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, issued an RFP posted January 20, 2026 with a March 26, 2026 response deadline to establish multiple contracts for generic multi-source pharmaceuticals and OTC products across Minnesota and Oregon participants, requiring vendors to supply through three authorized wholesalers (AmerisourceBergen Drug Corporation, Cardinal Health, and Morris & Dickson Co., LLC) with contract effectiveness targeted for July 1, 2026. Vendors must maintain $5 million commercial general liability insurance, certify cGMP and DSCSA compliance, and accept a 3 percent administrative fee on all purchases.